Wealthfront Advisers LLC Invests $1.43 Million in Bath & Body Works, Inc. $BBWI

Wealthfront Advisers LLC acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 61,912 shares of the company's stock, valued at approximately $1,432,000.

Other large investors also recently modified their holdings of the company. Global Retirement Partners LLC acquired a new position in Bath & Body Works in the fourth quarter valued at $31,000. Activest Wealth Management acquired a new stake in Bath & Body Works during the 4th quarter worth about $32,000. Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC grew its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after acquiring an additional 567 shares during the period. Finally, Danske Bank A S bought a new position in shares of Bath & Body Works in the 3rd quarter worth about $39,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on BBWI shares. TD Cowen boosted their price objective on Bath & Body Works from $20.00 to $25.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Raymond James Financial reiterated a "market perform" rating on shares of Bath & Body Works in a report on Wednesday, May 27th. UBS Group reissued a "neutral" rating on shares of Bath & Body Works in a research note on Wednesday. Wells Fargo & Company increased their price target on Bath & Body Works from $25.00 to $26.00 and gave the stock an "overweight" rating in a report on Tuesday, June 23rd. Finally, Piper Sandler initiated coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They set a "neutral" rating and a $20.00 price objective for the company. Four analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $22.57.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $19.47 on Friday. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $32.32. The stock has a 50 day moving average price of $20.47 and a two-hundred day moving average price of $20.10. The stock has a market capitalization of $3.92 billion, a PE ratio of 5.47, a price-to-earnings-growth ratio of 1.94 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the prior year, the firm earned $0.49 earnings per share. Bath & Body Works's revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works's dividend payout ratio (DPR) is 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source